News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Baeuerle Patrick
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/21/2023 |
4
| Baeuerle Patrick (Chief Scientific Officer) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Granted 38,500 shares
@ $0
Granted 77,000 options to buy
@ $11.34, valued at
$873.2k
|
|
| 02/15/2022 |
4
| Baeuerle Patrick (See Remarks) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Granted 37,500 shares
@ $0
Granted 75,000 options to buy
@ $13.6, valued at
$1M
|
|
| 09/09/2021 |
4
| Baeuerle Patrick (See Remarks) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Sold 11,000 shares
@ $28.45, valued at
$313k
Exercised 11,000 options to buy
@ $4.3, valued at
$47.3k
|
|
| 08/26/2021 |
4
| Baeuerle Patrick (See Remarks) has filed a Form 4 on Cullinan Oncology, Inc.|
Txns:
| Sold 11,000 shares
@ $27, valued at
$297k
Exercised 11,000 options to buy
@ $4.3, valued at
$47.3k
|
|
| 01/11/2021 |
4
| Baeuerle Patrick (See Remarks) has filed a Form 4 on Cullinan Management, Inc.|
Txns:
| Granted 286,665 options to buy
@ $21, valued at
$6M
|
|
| 01/07/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/11/2020 |
4
| Baeuerle Patrick (Director) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Granted 12,100 options to buy
@ $31.83, valued at
$385.1k
|
|
| 06/01/2020 |
4
| Baeuerle Patrick (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 10,167 options to buy
@ $20.59, valued at
$209.3k
Granted 2,584 options to buy
@ $20.59, valued at
$53.2k
|
|
| 12/30/2019 |
4
| Baeuerle Patrick (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Sold 75,562 shares
@ $15.8138, valued at
$1.2M
Sold 10,417 shares
@ $16.9014, valued at
$176.1k
Sold 1,400 shares
@ $18.069, valued at
$25.3k
|
|
| 12/26/2019 |
4
| Baeuerle Patrick (Director) has filed a Form 4 on TCR2 THERAPEUTICS INC.|
Txns:
| Sold 32,022 shares
@ $15.16, valued at
$485.5k
Sold 84,907 shares
@ $15.44, valued at
$1.3M
|
|
| 06/05/2019 |
4
| Baeuerle Patrick (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 10,167 options to buy
@ $11.84, valued at
$120.4k
|
|
| 04/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2019 |
4
| Baeuerle Patrick (Director) has filed a Form 4 on Harpoon Therapeutics, Inc.|
Txns:
| Granted 3,829 options to buy
@ $14, valued at
$53.6k
|
|
| 02/13/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/07/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/09/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/06/2012 |
4
| Baeuerle Patrick (SVP, CSO) has filed a Form 4 on MICROMET, INC.|
Txns:
| Unknown transaction of 16,266 shares
@ $11, valued at
$178.9k
|
|
| 04/05/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/09/2010 |
5
| Baeuerle Patrick (SVP, Chief Scientific Officer) has filed a Form 5 on MICROMET, INC. |
| 02/02/2010 |
4
| Baeuerle Patrick (SVP, CSO) has filed a Form 4 on MICROMET, INC.|
Txns:
| Granted 36,458 options to buy
@ $3.16, valued at
$115.2k
|
|
| 04/03/2009 |
4
| Baeuerle Patrick (SVP & CSO) has filed a Form 4 on MICROMET, INC. |
| 03/24/2009 |
4
| Baeuerle Patrick (SVP & CSO) has filed a Form 4 on MICROMET, INC. |
|
|